Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A22854 | 24251709 | J Gastroenterol Hepatol | Treatment of non-alcoholic fatty liver disease. | 2013 | Details |
A22855 | 24251708 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease: factors associated with its presence and onset. | 2013 | Details |
A22858 | 24251704 | J Gastroenterol Hepatol | Obesity and gastrointestinal liver disorders in Japan. | 2013 | Details |
A22863 | 24268461 | Arch Gerontol Geriatr | Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD? | 2013 | Details |
A22865 | 24267865 | Liver Int | Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. | 2013 | Details |
A22868 | 24265809 | PLoS One | Antidiabetic effects of chamomile flowers extract in obese mice through transcriptional stimulation of nutrient sensors of the peroxisome proliferator-activated receptor (PPAR) family. | 2013 | Details |
A22869 | 24265237 | Compr Physiol | Steatosis in the liver. | 2013 | Details |
A22870 | 24264333 | Chest | Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea. | 2014 | Details |
A22871 | 24264040 | Int J Mol Sci | Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment. | 2013 | Details |
A22874 | 24262589 | Clin Nutr | Diets and nonalcoholic fatty liver disease: the good and the bad. | 2013 | Details |
A22880 | 24258517 | Semin Immunopathol | CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). | 2013 | Details |
A22883 | 24256086 | Am J Respir Crit Care Med | Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance. | 2014 | Details |
A22888 | 24251213 | Indian J Endocrinol Metab | Correlation between liver fat content with dyslipidemia and Insulin resistance. | 2013 | Details |
A22889 | 24250305 | Afr Health Sci | Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver. | 2013 | Details |
A22891 | 24249635 | FASEB J | Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. | 2013 | Details |
A22893 | 24246334 | Endocr Pract | Obstructive sleep apnea predisposes to nonalcoholic Fatty liver disease in patients with polycystic ovary syndrome. | 2014 | Details |
A22896 | 24235062 | World J Pediatr | Type 2 diabetes mellitus in pediatrics: a new challenge. | 2013 | Details |
A22900 | 24223115 | PLoS One | Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease. | 2013 | Details |
A22901 | 24222948 | World J Gastroenterol | Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection. | 2013 | Details |
A22902 | 24222944 | World J Gastroenterol | Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. | 2013 | Details |
A22904 | 24222095 | Semin Liver Dis | Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease. | 2013 | Details |
A22918 | 24211299 | Gastroenterology | Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. | 2013 | Details |
A22923 | 24206666 | Cell Metab | Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler. | 2013 | Details |
A22924 | 24206551 | Rev Esp Enferm Dig | Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease. | 2013 | Details |
A22926 | 24205731 | Nihon Rinsho | [An inhibitor of intestinal cholesterol transporter]. | 2013 | Details |
A22928 | 24205128 | PLoS One | Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of Non-Alcoholic Fatty Liver Disease. | 2013 | Details |
A22933 | 24196354 | Int J Mol Sci | Hepatic adverse effects of fructose consumption independent of overweight/obesity. | 2013 | Details |
A22946 | 24187469 | World J Gastroenterol | Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. | 2013 | Details |
A22947 | 24187449 | World J Gastroenterol | Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease. | 2013 | Details |
A22949 | 24185692 | Nat Med | Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. | 2013 | Details |
A22950 | 24184549 | Sci Total Environ | Bisphenol A and cardiometabolic risk factors in obese children. | 2013 | Details |
A22952 | 24179926 | J Clin Diagn Res | Bardet biedel syndrome: a very rare entity in India. | 2013 | Details |
A22954 | 24179614 | World J Hepatol | Lipotoxicity in the liver. | 2013 | Details |
A22957 | 24176233 | Nutr Res | Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. | 2013 | Details |
A22959 | 24173405 | Int J Obes (Lond) | Inhibition of adipogenesis in 3T3-L1 cells and suppression of abdominal fat accumulation in high-fat diet-feeding C57BL/6J mice after downregulation of hyaluronic acid. | 2013 | Details |
A22962 | 24172912 | Eur J Gastroenterol Hepatol | Hematocrit is associated with fibrosis in patients with nonalcoholic steatohepatitis. | 2014 | Details |
A22964 | 24170649 | J Am Assoc Nurse Pract | Correlates of nonalcoholic fatty liver among women receiving residential mental health care. | 2012 | Details |
A22965 | 24167955 | Arch Latinoam Nutr | Prevention of liver steatosis through fish oil supplementation: correlation of oxidative stress with insulin resistance and liver fatty acid content. | 2013 | Details |
A22967 | 24161963 | Eur J Gastroenterol Hepatol | Impaired left ventricular mechanics in nonalcoholic fatty liver disease: a speckle-tracking echocardiography study. | 2014 | Details |
A22969 | 24160775 | Lipids Health Dis | Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional study. | 2013 | Details |
A22970 | 24159791 | Klin Med (Mosk) | [Additional advantages of mexicor used in combined therapy of coronary heat disease and diabetes mellitus of 2nd type]. | 2013 | Details |
A22973 | 24152749 | Nutrients | Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). | 2013 | Details |
A22975 | 24151364 | World J Gastroenterol | Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans. | 2013 | Details |
A22976 | 24151157 | Pediatr Obes | Alanine aminotransferase and metabolic syndrome in adolescents: the Korean National Health and Nutrition Examination Survey Study. | 2013 | Details |
A22977 | 24150574 | Aging Clin Exp Res | Adipocyte-fatty acid binding protein and non-alcoholic fatty liver disease in the elderly. | 2013 | Details |
A22980 | 24140091 | Metabolism | Irisin in patients with nonalcoholic fatty liver disease. | 2013 | Details |
A22981 | 24140006 | Prostaglandins Leukot Essent Fatty Acids | A diet high in α-linolenic acid and monounsaturated fatty acids attenuates hepatic steatosis and alters hepatic phospholipid fatty acid profile in diet-induced obese rats. | 2013 | Details |
A22984 | 24134687 | Eur J Clin Invest | Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease. | 2013 | Details |
A22989 | 24133660 | Clin Mol Hepatol | Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. | 2013 | Details |
A22991 | 24132155 | Int J Mol Sci | Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). | 2013 | Details |
A22993 | 24130687 | PLoS One | Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults. | 2013 | Details |
A22995 | 24130212 | Hum Exp Toxicol | Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease. | 2013 | Details |
A22996 | 24129399 | Am J Physiol Endocrinol Metab | Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet. | 2013 | Details |
A22999 | 24124336 | World J Gastroenterol | Association between UCP3 gene polymorphisms and nonalcoholic fatty liver disease in Chinese children. | 2013 | Details |
A23004 | 24119851 | Semin Nephrol | Race and the insulin resistance syndrome. | 2013 | Details |
A23006 | 24119413 | BMC Complement Altern Med | Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease. | 2013 | Details |
A23007 | 24119357 | Acad Radiol | MRI-diagnosed nonalcoholic fatty liver disease is correlated to insulin resistance in adolescents. | 2013 | Details |
A23018 | 24114821 | Ann Hepatol | Metabolic syndrome and nonalcoholic fatty liver disease. The role of endothelial progenitor cells. | 2014 | Details |
A23019 | 24114819 | Ann Hepatol | Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis. | 2014 | Details |
A23021 | 24113587 | Int J Mol Sci | Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks. | 2013 | Details |
A23023 | 24106929 | Liver Int | Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease. | 2013 | Details |
A23029 | 24098813 | PLoS One | Fatty liver is associated with transcriptional downregulation of stearoyl-CoA desaturase and impaired protein dimerization. | 2013 | Details |
A23059 | 24073298 | World J Hepatol | Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease. | 2013 | Details |
A23060 | 24072087 | J Clin Res Pediatr Endocrinol | Relationship between aspartate aminotransferase-to-platelet ratio index and carotid intima-media thickness in obese adolescents with non-alcoholic fatty liver disease. | 2013 | Details |
A23064 | 24070151 | Expert Rev Gastroenterol Hepatol | Is there any link between dietary pattern and development of nonalcoholic fatty liver disease in adolescence? An expert review. | 2013 | Details |
A23068 | 24067262 | Ann Hepatol | Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index. | 2014 | Details |
A23077 | 24064253 | Clin Nutr | Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. | 2013 | Details |
A23081 | 24059726 | Mini Rev Med Chem | Hepatic diseases related to triglyceride metabolism. | 2013 | Details |
A23093 | 24045866 | Am J Physiol Endocrinol Metab | The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell ATP homeostasis. | 2013 | Details |
A23097 | 24042449 | Nat Rev Gastroenterol Hepatol | The global NAFLD epidemic. | 2013 | Details |
A23107 | 24036369 | Int Immunopharmacol | Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway. | 2013 | Details |
A23112 | 24033085 | Eur J Clin Invest | Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis. | 2013 | Details |
A23113 | 24030232 | Dig Dis | Liver complications in inflammatory bowel diseases. | 2013 | Details |
A23117 | 24028151 | Diabetes Technol Ther | Comparison of characteristics between nonobese and overweight/obese subjects with nonalcoholic fatty liver disease in a South Indian population. | 2013 | Details |
A23125 | 24020975 | Curr Drug Targets | Biomarkers for early detection of non-alcoholic steatohepatitis: implications for drug development and clinical trials. | 2013 | Details |
A23130 | 24018165 | Semin Cancer Biol | Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease. | 2013 | Details |
A23131 | 24018052 | Gastroenterology | Therapeutic potential of fecal microbiota transplantation. | 2013 | Details |
A23132 | 24016432 | Zhonghua Liu Xing Bing Xue Za Zhi | [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China]. | 2013 | Details |
A23133 | 24015600 | Adv Clin Chem | Markers in nonalcoholic steatohepatitis. | 2013 | Details |
A23134 | 24011768 | Med Hypotheses | Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori. | 2013 | Details |
A23135 | 24011648 | Gastroenterol Hepatol | [Alcoholic and non-alcoholic steatohepatitis: who is affected and what can we do for them?]. | 2013 | Details |
A23136 | 24010297 | Zhongguo Zhong Yao Za Zhi | [Investigation of a compound, compatibility of Rhodiola crenulata, Cordyceps militaris, and Rhum palmatum, on metabolic syndrome treatment. IV--Improving liver lipid accumulation]. | 2013 | Details |
A23139 | 24009255 | Diabetes | Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity. | 2013 | Details |
A23140 | 24008607 | Minerva Med | Frequency of metabolic syndrome and 25-hydroxyvitamin D3 levels in patients with non-alcoholic fatty liver disease. | 2013 | Details |
A23144 | 24006666 | Zhen Ci Yan Jiu | [Influence of electroacupuncture stimulation on serum and hepatic interleukin-18 expression in nonalcoholic fatty liver rats]. | 2013 | Details |
A23152 | 24002036 | Endocrinology | Maternal hypoxia increases the susceptibility of adult rat male offspring to high-fat diet-induced nonalcoholic fatty liver disease. | 2013 | Details |
A23157 | 23997767 | Int J Endocrinol | Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY). | 2013 | Details |
A23160 | 23996808 | Hepatology | Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. | 2014 | Details |
A23161 | 23996518 | Horm Metab Res | Olive oil attenuates the cholesterol-induced development of nonalcoholic steatohepatitis despite increased insulin resistance in a rodent model. | 2013 | Details |
A23162 | 23994650 | Transl Res | The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes. | 2013 | Details |
A23163 | 23994574 | Free Radic Biol Med | Free radical biology for medicine: learning from nonalcoholic fatty liver disease. | 2013 | Details |
A23167 | 23990360 | Diabetes | Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease. | 2013 | Details |
A23169 | 23834053 | Nutr Hosp | Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism. | 2013 | Details |
A23170 | 23985808 | Am J Clin Nutr | Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism. | 2013 | Details |
A23171 | 23985000 | Expert Rev Gastroenterol Hepatol | Leptin in the treatment of lipodystrophy-associated nonalcoholic fatty liver disease: are we there already? | 2013 | Details |
A23173 | 23983685 | Int J Endocrinol | Low bone mineral density in chinese adults with nonalcoholic Fatty liver disease. | 2013 | Details |
A23180 | 23981577 | Cancer Lett | Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions. | 2013 | Details |
A23183 | 23980352 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease]. | 2013 | Details |
A23185 | 23978414 | Food Chem Toxicol | Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease. | 2013 | Details |
A23186 | 23977033 | PLoS One | Association of genetic variation in adaptor protein APPL1/APPL2 loci with non-alcoholic fatty liver disease. | 2013 | Details |